Financing, Equity Capital Markets
Crinetics Pharmaceuticals, Inc.
09/23
|
$350.0 Million
Âé¶¹´«Ã½ served as bookrunner for Crinetics Pharmaceuticals, Inc. on a follow-on offering -
Sub-Type
Follow-On Offering
Sector
Sub-Sector
Biopharma